Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1472 | Pituitary Clinical | ICEECE2012

Acromegaly, does tumor size matters?

Serra F , Duarte S , Ferreira R , Moniz C , Simoes H , Marques C , Azinheira J , Saraiva C , Saraiva M

Introduction: Acromegaly is a rare disease which results from a GH producing adenoma. Around 70–80% are macroadenomas. The therapeutic options currently available are surgery, radiotherapy (RT) and medical treatment (MT). According to literature microadenomas have a higher remission rate, around 80%.Methods: A retrospective chart review of the patients with acromegaly treated in our centre from 1976 to 2011 was performed. In terms of disease control...